Here's Why Salesforce (CRM) is a Strong Momentum Stock
Source: zacks.com
Salesforce shares gained 13.4% over the past four weeks, supported by an A Momentum Score and A VGM Score despite a Zacks Rank of #3 (Hold). Nineteen analysts raised fiscal 2027 EPS estimates over the past 60 days, lifting the consensus by $2.46 to $16.58 per share; Salesforce has also delivered an average earnings surprise of 36.1%. The article highlights the company’s Agentforce 360 AI-enabled CRM platform and improved earnings expectations as positive momentum factors.
Analysis
The estimate-revision impulse is potentially more relevant than the technical signal, but the article does not establish whether the higher FY27 base reflects durable Agentforce monetization, a lower tax/share-count assumption, or ordinary consensus catch-up. For CRM, the key valuation transmission is whether AI-related subscription and data-cloud growth can accelerate without re-expanding sales-and-marketing expense; sustained operating leverage would support multiple durability, while incremental services or incentive spend would leave the market treating the revisions as low-quality.
Over the next 1-3 months, CRM needs independent confirmation through remaining-performance-obligation growth, net-new annual contract value, Data Cloud attach rates, and management commentary on conversion from AI pilots to paid production deployments. The immediate consensus risk is that upward EPS revisions and recent price strength pull in systematic momentum flows before revenue evidence arrives, raising post-earnings downside asymmetry. A meaningful deceleration in cRPO, renewed large-deal scrutiny, or guidance that attributes EPS upside primarily to buybacks/cost controls rather than growth would falsify the constructive thesis.
Competitive read-through is mixed: successful enterprise AI cross-sell would pressure NOW, HUBS and ORCL at the application layer, but it may also validate broader enterprise-software budget resilience rather than create zero-sum displacement. The contrarian view is that AI enthusiasm is already capitalized into large-cap software valuations; CRM's differentiated upside requires evidence that its unified data layer produces higher seat expansion or pricing power, not merely bundled functionality that protects its installed base.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.42
Ticker Sentiment
Key Decisions for Investors
- Do not chase the current momentum signal outright; place CRM on an earnings-confirmation watchlist for the next report. Initiate only if cRPO and subscription growth meet or exceed guidance while operating margin holds, indicating revisions are revenue-backed rather than expense-driven.
- For a 1-3 month relative-value expression after confirmation, long CRM versus short IGV or a basket of NOW/HUBS sized beta-neutral. Target 8-12% relative upside if AI conversion broadens; exit on cRPO deceleration or a material reduction in FY27 revenue guidance.
- For existing CRM longs, protect the event window with a 5-10% out-of-the-money put spread rather than add spot exposure after a sharp run. The defined-risk hedge addresses the risk that elevated expectations convert a merely in-line print into multiple compression.
- No action in NNOX: its inclusion is promotional cross-reference rather than a fundamental linkage to CRM, and there is no information here supporting a change in earnings, liquidity, or operating outlook.
More News
- A rare Microsoft bear warms up to the stock. Here's what changed their mind
- IT services stock is up 89%+ since July - our AI models picked it first
- Salesforce is set to rebound after a recent pullback. How trader Tony Zhang is playing the bounce
- Typical job search advice isn't working in today's market. Experts' new rules for landing a role right now
- China's AI chip blitz arms Xi with a message for Trump: 'You can't choke us off'
- OpenAI’s agent hacked Australia’s Medicare website—the latest rogue AI incident that the company didn’t know about for months